Results 61 to 70 of about 57,781 (271)
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
International Journal of COPD, 2019 James F Donohue,1 Donald A Mahler,2,3 Sanjay Sethi4 1Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA; 2Geisel School of Medicine at Dartmouth, Hanover, NH, USA; 3Director of Respiratory Services, Valley Regional Hospital, Claremont, NH ...
Donohue JF, Mahler DA, Sethi S
doaj
Pharmacological therapy for stable chronic obstructive pulmonary disease
Chronic Diseases and Translational Medicine, 2023 In recent years, emphasis has shifted from preventing and treating chronic obstructive pulmonary disease (COPD) to early prevention, early treatment, and disease stabilization, with the main goal of improving patients’ quality of life and reducing the ...
Ruirui Duan, Baicun Li, Ting Yang
doaj +1 more source
Journal of Clinical Ultrasound, EarlyView.This study is to assess the predictive value of the modified lung ultrasound score (mLUS) for late respiratory diseases in premature infants born before 32 weeks of gestation. It is recommended that the use of mLUS scoring be promoted in clinical practice for the early screening of high‐risk preterm infants.
Shuang Zheng +4 more
wiley +1 more source
New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma [PDF]
, 2017 Introduction: Inhaled corticosteroids (ICS) alone or in combination with an inhaled long-acting beta2-agonist (LABA) are the preferred long-term treatment for adults and adolescents with symptomatic asthma.
Thomson, Neil C.
core +1 more source
The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation [PDF]
, 2002 Background: This review examines the clinical effectiveness and cost-effectiveness of hand-held inhalers to deliver medication for the routine management of chronic asthma in children aged between 5 and 15 years.
Beverley, C. +4 more
core +1 more source
Journal of Hospital Medicine, EarlyView.Abstract Background Low‐value care remains prevalent in bronchiolitis management despite evidence‐based guidelines. De‐implementation initiatives face unique challenges compared with traditional implementation efforts, particularly when spreading across diverse healthcare settings.
Nathan M. Solbak +7 more
wiley +1 more source
Dual inhibitory activities of Adhatoda Vasica against cyclooxygenase and lipoxygenase
International Journal of Endorsing Health Science Research, 2013 Adhatoda vasica (L.) Nees is a well-known plant drug in Ayurvedic and Unani medicine. It has been used for the treatment of various diseases, particularly for the treatment of inflammatory and cardiovascular diseases.
Sagheer Ahmed +3 more
doaj +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Pediatric asthma is a common chronic airway inflammatory disease, where accurate assessment of disease severity and prognosis prediction is crucial for treatment decisions. Currently, there is a lack of precise and effective biomarkers.
Xu Yang +5 more
wiley +1 more source
Acute bronchitis: challenges of diagnosis and treatment
Медицинский совет, 2013 Internal medicine specialists often have difficulty in making diagnosis and defining the type of treatment for patients with first time long-lasting cough or newly developed bronchial obstruction syndrome. Acute bronchitis (AB) is one of reasons of cough
I. V. Leschenko
doaj +1 more source
Temporal and Partial Reversal of Airflow Limitation in Patients With COPD Treated With Single-Inhaler Long-Acting Dual Bronchodilators. [PDF]
Clin Respir JSingle‐inhaler dual bronchodilator therapy significantly improved FEV1, FEV1/FVC, and other spirometry parameters in patients with COPD. The improvements in FEV1 and FEV1/FVC exhibits different trends. Notably, 21 patients (11.5%) achieved a reversal of the FEV1/FVC ratio to over 70%.
Lu Y +10 more
europepmc +2 more sources